Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Idacio 40mg/0.8ml solution for injection pre-filled syringes
1001030S0BGACAA
|
Idacio | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Idacio 40mg/0.8ml solution for injection vials
1001030S0BGAAAC
|
Idacio | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Idarubicin 10mg capsules
0801020P0AAADAD
|
Idarubicin hydrochloride | Idarubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Idarubicin 10mg powder for solution for injection vials
0801020P0AAABAB
|
Idarubicin hydrochloride | Idarubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Idarubicin 10mg/10ml solution for injection vials
0801020P0AAAFAF
|
Idarubicin hydrochloride | Idarubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Idarubicin 25mg capsules
0801020P0AAAEAE
|
Idarubicin hydrochloride | Idarubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Idarubicin 5mg capsules
0801020P0AAACAC
|
Idarubicin hydrochloride | Idarubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Idarubicin 5mg powder for solution for injection vials
0801020P0AAAAAA
|
Idarubicin hydrochloride | Idarubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Idarubicin 5mg/5ml solution for injection vials
0801020P0AAAGAG
|
Idarubicin hydrochloride | Idarubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Idarucizumab 2.5g/50ml solution for infusion vials
0208040A0AAAAAA
|
Idarucizumab | Idarucizumab | Cardiovascular System | No data available |
|
Idebenone 45mg tablets
1108030ABAAAAAA
|
Idebenone | Idebenone | Eye | No data available |
|
Idoxuridine 5% topical solution
1310030I0AAADAD
|
Idoxuridine in dimethyl sulfoxide | Idoxuridine in dimethyl sulfoxide | Skin | No data available |
|
Idrocath catheter child 8Ch-10Ch
21020001123
|
Idrocath catheter child 8Ch-10Ch | Catheters | Appliances | No data available |
|
Idrocath catheter male 8Ch-24Ch
21020001120
|
Idrocath catheter male 8Ch-24Ch | Catheters | Appliances | No data available |
|
Idrocath catheter male Tiemann tip 10Ch-20Ch
21020001124
|
Idrocath catheter male Tiemann tip 10Ch-20Ch | Catheters | Appliances | No data available |
|
Idrocath catheter paediatric 6Ch-10Ch
21020001122
|
Idrocath catheter paediatric 6Ch-10Ch | Catheters | Appliances | No data available |
|
Idrocath dilatation catheter male 16Ch-18Ch
21020001130
|
Idrocath dilatation catheter male 16Ch-18Ch | Catheters | Appliances | No data available |
|
Idrocath Kit catheter child 8Ch-10Ch
21020001143
|
Idrocath Kit catheter child 8Ch-10Ch | Catheters | Appliances | No data available |
|
Idrocath Kit catheter female 8Ch-18Ch
21020001141
|
Idrocath Kit catheter female 8Ch-18Ch | Catheters | Appliances | No data available |
|
Idrocath Kit catheter male 8Ch-24Ch
21020001140
|
Idrocath Kit catheter male 8Ch-24Ch | Catheters | Appliances | No data available |
|
Idrocath Kit catheter male Tiemann tip 10Ch-18Ch
21020001144
|
Idrocath Kit catheter male Tiemann tip 10Ch-18Ch | Catheters | Appliances | No data available |
|
Idrocath Kit catheter paediatric 6Ch-10Ch
21020001142
|
Idrocath Kit catheter paediatric 6Ch-10Ch | Catheters | Appliances | No data available |
|
Idrolax 10g oral powder sachets
0106040X0BBAAAA
|
Idrolax | Macrogol 4000 | Gastro-Intestinal System | No data available |
|
Ifosfamide 1g powder for solution for injection vials
0801010N0AAABAB
|
Ifosfamide | Ifosfamide | Malignant Disease and Immunosuppression | No data available |
|
Ifosfamide 2g powder for solution for injection vials
0801010N0AAACAC
|
Ifosfamide | Ifosfamide | Malignant Disease and Immunosuppression | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.